Insulin costs have risen rapidly over the last few years but improving insulin safety can actually reduce insulin expense.
Digital Hospital Inc.'s device allows the use of 'ward stock' insulin vials with zero risk of cross contamination
Hospitals currently using pens for both long and short acting insulins can recoup 100% of the device cost within 13 months.
Hospitals using patient specific vials for both long and short acting insulins can recoup their investment in as little as 3 months.
To discover how long it would take you to reach your breakeven point by reducing insulin expense, please use our Savings Calculator.
Insulin is a potentially fatal drug, and is the drug most frequently involved in harmful medication errors -- more than morphine, fentanyl, heparin, or warfarin. (See Footnote 1)
There is no effective mechanism to prevent insulin dosing errors from being administered to patients.
Digital Hospital, Inc.
Digital Hospital, Inc.'s device connects with the Electronic Health Record (EHR) in order to match the patient's blood glucose to the Doctor's order, then validates that the nurse has drawn up the amount of insulin specified in the Doctor's order. When the dose has been confirmed, the device prints a barcode for the insulin syringe which is scanned at the bedside before administration. (See Demo of Initial Prototype)
Double-checking the insulin dose can reduce insulin dosing errors hospitals of 95%. (See Footnote 2)
Patient's vulnerability caused by imprecise manual measurement, misinterpretation of blood-glucose-based orders or manual data entry is eliminated.